Basel Medical Group Ltd (BMGL)
NASDAQ · Healthcare
Basel Medical Group Ltd EBITDA 2022–2025
Basel Medical Group Ltd annual/quarterly ebitda history and growth rate from 2022 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Basel Medical Group Ltd annual ebitda for 2025 was 680757, a 78.11% decrease from 2024.
- Basel Medical Group Ltd annual ebitda for 2024 was 3.1 M, a 6.23% increase from 2023.
- Basel Medical Group Ltd annual ebitda for 2023 was 2.9 M, a 16.58% increase from 2022.
- Basel Medical Group Ltd annual ebitda for 2022 was 2.5 M.
No data available.
Basel Medical Group Ltd EBITDA — FAQ
Basel Medical Group Ltd (BMGL) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMGL's ebitda history?
The chart and table above show Basel Medical Group Ltd's ebitda by year and by quarter, including the growth rate.